Moffitt Cancer Center’s Howard L. McLeod to Receive Russell R. Miller Award

October 12, 2015

TAMPA, Fla. – Howard L. McLeod, PharmD, FCCP, medical director of the DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center, will receive with the prestigious Russell R. Miller Award at the American College of Clinical Pharmacy Global Conference in San Francisco. The award presentation will occur during the conference’s opening session on Oct. 18.

The Russell R. Miller Award recognizes an individual’s substantial contributions to the literature of clinical pharmacy, thereby advancing both clinical pharmacy practice and rational pharmacotherapy.  McLeod had published almost 500 peer-reviewed manuscripts, 26 book chapters and more than 300 abstracts.

“Dr. McLeod is at the forefront of oncology precision medicine. His research has given clinicians and researchers a better understanding of how genetics can impact the effectiveness of medication and why it should be used when establishing a treatment plan,” said Thomas A. Sellers, Ph.D., M.P.H., center director at Moffitt.

McLeod serves as an editorial board member for Biomarkers in Medicine, Personalized Medicine, Pharmacogenetics and Genomics, and Pharmacogenomics; and as a reviewer for several prestigious journals, including Clinical Pharmacology and Therapeutics, Journal of the American Medical Association, Lancet, Nature Genetics, Nature Medicine, New England Journal of Medicine, and Science. The American College of Clinical Pharmacy has bestowed several honors on McLeod, including the Therapeutic Frontiers Lecture Award in 2008, Fellow recognition in 2004 and the New Investigator Award in 2000.

About Moffitt Cancer Center

Located in Tampa, Moffitt is one of only 45 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in Florida and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. With more than 4,600 team members, Moffitt has an economic impact in the state of $1.9 billion. For more information, visit, and follow the Moffitt momentum on Facebook, Twitter and YouTube.